1. Home
  2. RMD vs CAH Comparison

RMD vs CAH Comparison

Compare RMD & CAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RMD
  • CAH
  • Stock Information
  • Founded
  • RMD 1989
  • CAH 1979
  • Country
  • RMD United States
  • CAH United States
  • Employees
  • RMD N/A
  • CAH N/A
  • Industry
  • RMD Medical/Dental Instruments
  • CAH Other Pharmaceuticals
  • Sector
  • RMD Health Care
  • CAH Health Care
  • Exchange
  • RMD Nasdaq
  • CAH Nasdaq
  • Market Cap
  • RMD 36.7B
  • CAH 39.9B
  • IPO Year
  • RMD 1995
  • CAH N/A
  • Fundamental
  • Price
  • RMD $254.41
  • CAH $161.33
  • Analyst Decision
  • RMD Buy
  • CAH Buy
  • Analyst Count
  • RMD 12
  • CAH 15
  • Target Price
  • RMD $259.40
  • CAH $154.07
  • AVG Volume (30 Days)
  • RMD 748.6K
  • CAH 2.5M
  • Earning Date
  • RMD 07-31-2025
  • CAH 08-13-2025
  • Dividend Yield
  • RMD 0.82%
  • CAH 1.27%
  • EPS Growth
  • RMD 37.08
  • CAH 155.27
  • EPS
  • RMD 8.91
  • CAH 6.38
  • Revenue
  • RMD $5,021,529,000.00
  • CAH $222,286,000,000.00
  • Revenue This Year
  • RMD $10.37
  • CAH N/A
  • Revenue Next Year
  • RMD $7.77
  • CAH $10.96
  • P/E Ratio
  • RMD $28.96
  • CAH $25.23
  • Revenue Growth
  • RMD 9.54
  • CAH 0.86
  • 52 Week Low
  • RMD $195.00
  • CAH $93.17
  • 52 Week High
  • RMD $263.05
  • CAH $168.44
  • Technical
  • Relative Strength Index (RSI)
  • RMD 52.85
  • CAH 49.46
  • Support Level
  • RMD $251.40
  • CAH $161.00
  • Resistance Level
  • RMD $261.08
  • CAH $168.07
  • Average True Range (ATR)
  • RMD 4.21
  • CAH 3.23
  • MACD
  • RMD -0.51
  • CAH -0.94
  • Stochastic Oscillator
  • RMD 34.28
  • CAH 1.69

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

About CAH Cardinal Health Inc.

Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.

Share on Social Networks: